1. Home
  2. OPEN vs ARQT Comparison

OPEN vs ARQT Comparison

Compare OPEN & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opendoor Technologies Inc

OPEN

Opendoor Technologies Inc

N/A

Current Price

$6.28

Market Cap

5.9B

Sector

Finance

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$28.17

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPEN
ARQT
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OPEN
ARQT
Price
$6.28
$28.17
Analyst Decision
Sell
Strong Buy
Analyst Count
4
7
Target Price
$1.88
$24.83
AVG Volume (30 Days)
89.4M
2.2M
Earning Date
11-06-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,719,000,000.00
$317,929,000.00
Revenue This Year
N/A
$85.51
Revenue Next Year
$16.54
$30.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
129.21
52 Week Low
$0.51
$11.13
52 Week High
$10.87
$31.77

Technical Indicators

Market Signals
Indicator
OPEN
ARQT
Relative Strength Index (RSI) 40.75 50.03
Support Level $6.25 $28.30
Resistance Level $7.23 $31.77
Average True Range (ATR) 0.54 1.11
MACD -0.09 -0.54
Stochastic Oscillator 1.24 1.37

Price Performance

Historical Comparison
OPEN
ARQT

About OPEN Opendoor Technologies Inc

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: